The US refractive surgery market showed signs of improvement in Q4-2010, though the unemployment rate is expected to constrain the rate of growth through the balance of 2011. Nonetheless, Market Scope has raised its 2011 forecast.
In Q4-2010, IVT injections continued to climb as laser photocoagulation procedures slipped and PDT procedures dropped precipitously. Vitrectomies fell very slightly during the quarter.
As the difficult economic period for laser vision correction begins to abate, we offer capsule profiles of seven of the leading global corporate laser centers.
We expect newer devices entering the market beginning in 2011 to fuel yearly global revenue growth of 9 percent in the retinal surgical device market.
This month's news includes the latest from Aquesys, Regeneron, Bayer Healthcare, Genentech, Bausch + Lomb, and SarCode Corporation.
You are not currently logged in.
©2018 Market Scope
Lost your Password